Optoceutics ApS — Credit Rating and Financial Key Figures
CVR number: 39769689
Nørrebrogade 45 C, 2200 København N
msc@optoceutics.com
tel: 23456442
www.optoceutics.com
Income statement (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | - 131.72 | 34.68 | 4 262.72 | 909.64 | - 519.34 |
| Employee benefit expenses | - 820.86 | -5 452.39 | -7 568.54 | -8 424.68 | -8 046.64 |
| Total depreciation | - 750.00 | - 535.66 | - 740.13 | ||
| EBIT | - 952.57 | -5 417.71 | -4 055.81 | -8 050.70 | -9 306.11 |
| Other financial income | 0.07 | 11.81 | 18.26 | 182.05 | |
| Other financial expenses | -77.17 | -68.56 | -1 007.93 | - 601.03 | - 944.18 |
| Pre-tax profit | -1 029.74 | -5 486.20 | -5 051.94 | -8 633.47 | -10 068.24 |
| Income taxes | 523.41 | 1 605.82 | 1 416.27 | 1 421.95 | 883.61 |
| Net earnings | - 506.33 | -3 880.38 | -3 635.66 | -7 211.52 | -9 184.63 |
Assets (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Development expenditure | 8 197.90 | 12 244.76 | 15 934.51 | 18 326.17 | 21 694.24 |
| Intangible rights | 588.70 | 629.38 | 825.76 | 1 800.62 | 1 708.83 |
| Intangible assets total | 8 786.60 | 12 874.14 | 16 760.28 | 20 126.79 | 23 403.07 |
| Tangible assets total | |||||
| Holdings in group member companies | 70.44 | 70.44 | |||
| Investments total | 54.71 | 114.15 | 481.67 | 416.02 | 201.96 |
| Long term receivables total | |||||
| Raw materials and consumables | 1 041.43 | 1 148.02 | 497.93 | ||
| Finished products/goods | 161.51 | 691.93 | 734.34 | 35.74 | |
| Inventories total | 161.51 | 1 733.36 | 1 882.36 | 533.68 | |
| Current trade debtors | 3.78 | 818.62 | |||
| Current amounts owed by group member comp. | 13.83 | 292.65 | 3 665.62 | ||
| Prepayments and accrued income | 1.38 | 61.82 | |||
| Current other receivables | 374.06 | 33.57 | 53.85 | 12 149.50 | 8 359.63 |
| Current deferred tax assets | 991.95 | 1 334.94 | 1 019.95 | 809.02 | 883.61 |
| Short term receivables total | 1 369.78 | 1 382.34 | 1 073.80 | 14 071.17 | 12 970.69 |
| Cash and bank deposits | 17 058.11 | 11 913.99 | 9 876.82 | 4 319.27 | 8 913.82 |
| Cash and cash equivalents | 17 058.11 | 11 913.99 | 9 876.82 | 4 319.27 | 8 913.82 |
| Balance sheet total (assets) | 27 269.20 | 26 446.13 | 29 925.92 | 40 815.61 | 46 023.22 |
Equity and liabilities (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Share capital | 82.05 | 82.90 | 89.03 | 97.01 | 103.30 |
| Other reserves | 6 394.36 | 9 550.91 | 12 428.92 | 26 099.11 | 24 097.24 |
| Retained earnings | 10 277.81 | 7 613.87 | 8 060.82 | 9 929.61 | 19 048.14 |
| Profit of the financial year | - 506.33 | -3 880.38 | -3 635.66 | -7 211.52 | -9 184.63 |
| Shareholders equity total | 16 247.89 | 13 367.31 | 16 943.11 | 28 914.21 | 34 064.06 |
| Provisions | 1 280.13 | 9 509.25 | 10 084.65 | ||
| Capital loans | 8 500.00 | 9 471.72 | 10 058.69 | 9 860.70 | |
| Non-current loans from credit institutions | 8 500.00 | ||||
| Non-current other liabilities | 245.59 | ||||
| Non-current liabilities total | 8 745.59 | 8 500.00 | 9 471.72 | 10 058.69 | 9 860.70 |
| Current loans from credit institutions | 1 116.75 | ||||
| Advances received | 1 289.37 | ||||
| Current trade creditors | 223.87 | 87.37 | 222.15 | 856.38 | |
| Other non-interest bearing current liabilities | 771.71 | 364.45 | 144.74 | 553.34 | 125.32 |
| Accruals and deferred income | 3 117.75 | 2 531.27 | |||
| Current liabilities total | 995.58 | 3 569.56 | 2 898.16 | 1 842.72 | 2 098.46 |
| Balance sheet total (liabilities) | 27 269.20 | 34 946.13 | 39 397.64 | 40 815.61 | 46 023.22 |
CreditReports API
- Company information
- Financial data
- Credit risk data
- All 400,000+ Danish companies
Try the full version of our system for free
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions
... and more!
No registration needed.